Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells

Xiao Dan Yu, Sheng Yu Wang, G. Aaron Chen, Chun Mei Hou, Ming Zhao, Julie A. Hong, Dao Nguyen, David S. Schrump

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background:: Whereas histone deacetylase inhibitors are known to modulate chromatin structure, the precise mechanisms by which these novel agents induce apoptosis in cancer cells remain unknown. Previously we reported that depsipeptide FK228 depletes epidermal growth factor receptor (EGFR), erbB2, and Raf-1 kinases in non-small cell lung cancer cells. In the present study we sought to further define the mechanisms by which FK228 modulates oncoprotein signaling and to ascertain whether altered signal transduction contributes to FK228-mediated apoptosis in lung cancer cells. Methods:: Cultured non-small cell lung cancer cells were treated with FK228 alone or FK228 with a variety of kinase inhibitors. Proliferation and apoptosis mediated by drug exposure were assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium, and Apo-BrdU techniques. Western blot and kinase assays were used to evaluate EGFR-related signal transduction pathways. Lung cancer cells were transduced with adenoviral vectors expressing activated AKT or mitogen-activated protein kinase kinase (MEK) 1 or β2-galactosidase to determine whether constitutive activation of mitogen-activated protein kinase signaling could abrogate FK228-mediated apoptosis. Results:: FK228 treatment induced time-dependent apoptosis in lung cancer cells expressing wild-type or mutant EGFR. FK228 inhibited a variety of EGFR-related pathways including Src, RAF-MEK-extracellular signal-regulated kinase (ERK) 1/2 and phosphatidyl inositol-3 kinase (PI3K)/AKT, resulting in down-regulation of Bcl-2 and Bcl-xL and up-regulation of Bax. The kinase inhibitors AG1478, AG825, PD98059, and LY294002 markedly enhanced FK228-induced apoptosis in lung cancer cells. Coincident with inhibition of ERK1/2 and PI3K/AKT survival pathways, FK228 enhanced p38 and stress-activated protein kinase/c-Jun NH2-terminal kinase stress signaling. Constitutive expression of MEK1 but not AKT markedly reduced FK228-mediated apoptosis in lung cancer cells. Conclusions:: FK228 inhibits EGFR expression and modulates a variety of downstream mediators regulating proliferation and stress responses in lung cancer cells. These data highlight the significance of MEK signaling with respect to FK228-mediated apoptosis and support evaluation of histone deacetylase inhibitors in conjunction with agents specifically targeting mitogen-activated protein kinases in patients with lung cancer.

Original languageEnglish
Pages (from-to)105-113
Number of pages9
JournalCancer Journal
Volume13
Issue number2
DOIs
StatePublished - Mar 1 2007
Externally publishedYes

Fingerprint

Depsipeptides
Lung Neoplasms
Apoptosis
Epidermal Growth Factor Receptor
Phosphotransferases
Mitogen-Activated Protein Kinase Kinases
Histone Deacetylase Inhibitors
Phosphatidylinositols
Mitogen-Activated Protein Kinases
Non-Small Cell Lung Carcinoma
romidepsin
Signal Transduction
MAP Kinase Kinase 2
Proto-Oncogene Proteins c-raf
MAP Kinase Kinase 1
Galactosidases
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Mitogen-Activated Protein Kinase 3
JNK Mitogen-Activated Protein Kinases
Oncogene Proteins

Keywords

  • Epigenetics
  • FK228
  • Lung cancer
  • Mitogen-activated protein kinase

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Yu, X. D., Wang, S. Y., Chen, G. A., Hou, C. M., Zhao, M., Hong, J. A., ... Schrump, D. S. (2007). Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells. Cancer Journal, 13(2), 105-113. https://doi.org/10.1097/PPO.0b013e318046eedc

Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells. / Yu, Xiao Dan; Wang, Sheng Yu; Chen, G. Aaron; Hou, Chun Mei; Zhao, Ming; Hong, Julie A.; Nguyen, Dao; Schrump, David S.

In: Cancer Journal, Vol. 13, No. 2, 01.03.2007, p. 105-113.

Research output: Contribution to journalArticle

Yu, Xiao Dan ; Wang, Sheng Yu ; Chen, G. Aaron ; Hou, Chun Mei ; Zhao, Ming ; Hong, Julie A. ; Nguyen, Dao ; Schrump, David S. / Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells. In: Cancer Journal. 2007 ; Vol. 13, No. 2. pp. 105-113.
@article{aef9f9650ee24644b74bd06d7fbe86fd,
title = "Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells",
abstract = "Background:: Whereas histone deacetylase inhibitors are known to modulate chromatin structure, the precise mechanisms by which these novel agents induce apoptosis in cancer cells remain unknown. Previously we reported that depsipeptide FK228 depletes epidermal growth factor receptor (EGFR), erbB2, and Raf-1 kinases in non-small cell lung cancer cells. In the present study we sought to further define the mechanisms by which FK228 modulates oncoprotein signaling and to ascertain whether altered signal transduction contributes to FK228-mediated apoptosis in lung cancer cells. Methods:: Cultured non-small cell lung cancer cells were treated with FK228 alone or FK228 with a variety of kinase inhibitors. Proliferation and apoptosis mediated by drug exposure were assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium, and Apo-BrdU techniques. Western blot and kinase assays were used to evaluate EGFR-related signal transduction pathways. Lung cancer cells were transduced with adenoviral vectors expressing activated AKT or mitogen-activated protein kinase kinase (MEK) 1 or β2-galactosidase to determine whether constitutive activation of mitogen-activated protein kinase signaling could abrogate FK228-mediated apoptosis. Results:: FK228 treatment induced time-dependent apoptosis in lung cancer cells expressing wild-type or mutant EGFR. FK228 inhibited a variety of EGFR-related pathways including Src, RAF-MEK-extracellular signal-regulated kinase (ERK) 1/2 and phosphatidyl inositol-3 kinase (PI3K)/AKT, resulting in down-regulation of Bcl-2 and Bcl-xL and up-regulation of Bax. The kinase inhibitors AG1478, AG825, PD98059, and LY294002 markedly enhanced FK228-induced apoptosis in lung cancer cells. Coincident with inhibition of ERK1/2 and PI3K/AKT survival pathways, FK228 enhanced p38 and stress-activated protein kinase/c-Jun NH2-terminal kinase stress signaling. Constitutive expression of MEK1 but not AKT markedly reduced FK228-mediated apoptosis in lung cancer cells. Conclusions:: FK228 inhibits EGFR expression and modulates a variety of downstream mediators regulating proliferation and stress responses in lung cancer cells. These data highlight the significance of MEK signaling with respect to FK228-mediated apoptosis and support evaluation of histone deacetylase inhibitors in conjunction with agents specifically targeting mitogen-activated protein kinases in patients with lung cancer.",
keywords = "Epigenetics, FK228, Lung cancer, Mitogen-activated protein kinase",
author = "Yu, {Xiao Dan} and Wang, {Sheng Yu} and Chen, {G. Aaron} and Hou, {Chun Mei} and Ming Zhao and Hong, {Julie A.} and Dao Nguyen and Schrump, {David S.}",
year = "2007",
month = "3",
day = "1",
doi = "10.1097/PPO.0b013e318046eedc",
language = "English",
volume = "13",
pages = "105--113",
journal = "Cancer journal (Sudbury, Mass.)",
issn = "1528-9117",
publisher = "Association Pour le Developpement de la Communication Cancerologique",
number = "2",

}

TY - JOUR

T1 - Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells

AU - Yu, Xiao Dan

AU - Wang, Sheng Yu

AU - Chen, G. Aaron

AU - Hou, Chun Mei

AU - Zhao, Ming

AU - Hong, Julie A.

AU - Nguyen, Dao

AU - Schrump, David S.

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Background:: Whereas histone deacetylase inhibitors are known to modulate chromatin structure, the precise mechanisms by which these novel agents induce apoptosis in cancer cells remain unknown. Previously we reported that depsipeptide FK228 depletes epidermal growth factor receptor (EGFR), erbB2, and Raf-1 kinases in non-small cell lung cancer cells. In the present study we sought to further define the mechanisms by which FK228 modulates oncoprotein signaling and to ascertain whether altered signal transduction contributes to FK228-mediated apoptosis in lung cancer cells. Methods:: Cultured non-small cell lung cancer cells were treated with FK228 alone or FK228 with a variety of kinase inhibitors. Proliferation and apoptosis mediated by drug exposure were assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium, and Apo-BrdU techniques. Western blot and kinase assays were used to evaluate EGFR-related signal transduction pathways. Lung cancer cells were transduced with adenoviral vectors expressing activated AKT or mitogen-activated protein kinase kinase (MEK) 1 or β2-galactosidase to determine whether constitutive activation of mitogen-activated protein kinase signaling could abrogate FK228-mediated apoptosis. Results:: FK228 treatment induced time-dependent apoptosis in lung cancer cells expressing wild-type or mutant EGFR. FK228 inhibited a variety of EGFR-related pathways including Src, RAF-MEK-extracellular signal-regulated kinase (ERK) 1/2 and phosphatidyl inositol-3 kinase (PI3K)/AKT, resulting in down-regulation of Bcl-2 and Bcl-xL and up-regulation of Bax. The kinase inhibitors AG1478, AG825, PD98059, and LY294002 markedly enhanced FK228-induced apoptosis in lung cancer cells. Coincident with inhibition of ERK1/2 and PI3K/AKT survival pathways, FK228 enhanced p38 and stress-activated protein kinase/c-Jun NH2-terminal kinase stress signaling. Constitutive expression of MEK1 but not AKT markedly reduced FK228-mediated apoptosis in lung cancer cells. Conclusions:: FK228 inhibits EGFR expression and modulates a variety of downstream mediators regulating proliferation and stress responses in lung cancer cells. These data highlight the significance of MEK signaling with respect to FK228-mediated apoptosis and support evaluation of histone deacetylase inhibitors in conjunction with agents specifically targeting mitogen-activated protein kinases in patients with lung cancer.

AB - Background:: Whereas histone deacetylase inhibitors are known to modulate chromatin structure, the precise mechanisms by which these novel agents induce apoptosis in cancer cells remain unknown. Previously we reported that depsipeptide FK228 depletes epidermal growth factor receptor (EGFR), erbB2, and Raf-1 kinases in non-small cell lung cancer cells. In the present study we sought to further define the mechanisms by which FK228 modulates oncoprotein signaling and to ascertain whether altered signal transduction contributes to FK228-mediated apoptosis in lung cancer cells. Methods:: Cultured non-small cell lung cancer cells were treated with FK228 alone or FK228 with a variety of kinase inhibitors. Proliferation and apoptosis mediated by drug exposure were assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium, and Apo-BrdU techniques. Western blot and kinase assays were used to evaluate EGFR-related signal transduction pathways. Lung cancer cells were transduced with adenoviral vectors expressing activated AKT or mitogen-activated protein kinase kinase (MEK) 1 or β2-galactosidase to determine whether constitutive activation of mitogen-activated protein kinase signaling could abrogate FK228-mediated apoptosis. Results:: FK228 treatment induced time-dependent apoptosis in lung cancer cells expressing wild-type or mutant EGFR. FK228 inhibited a variety of EGFR-related pathways including Src, RAF-MEK-extracellular signal-regulated kinase (ERK) 1/2 and phosphatidyl inositol-3 kinase (PI3K)/AKT, resulting in down-regulation of Bcl-2 and Bcl-xL and up-regulation of Bax. The kinase inhibitors AG1478, AG825, PD98059, and LY294002 markedly enhanced FK228-induced apoptosis in lung cancer cells. Coincident with inhibition of ERK1/2 and PI3K/AKT survival pathways, FK228 enhanced p38 and stress-activated protein kinase/c-Jun NH2-terminal kinase stress signaling. Constitutive expression of MEK1 but not AKT markedly reduced FK228-mediated apoptosis in lung cancer cells. Conclusions:: FK228 inhibits EGFR expression and modulates a variety of downstream mediators regulating proliferation and stress responses in lung cancer cells. These data highlight the significance of MEK signaling with respect to FK228-mediated apoptosis and support evaluation of histone deacetylase inhibitors in conjunction with agents specifically targeting mitogen-activated protein kinases in patients with lung cancer.

KW - Epigenetics

KW - FK228

KW - Lung cancer

KW - Mitogen-activated protein kinase

UR - http://www.scopus.com/inward/record.url?scp=34347261742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347261742&partnerID=8YFLogxK

U2 - 10.1097/PPO.0b013e318046eedc

DO - 10.1097/PPO.0b013e318046eedc

M3 - Article

C2 - 17476138

AN - SCOPUS:34347261742

VL - 13

SP - 105

EP - 113

JO - Cancer journal (Sudbury, Mass.)

JF - Cancer journal (Sudbury, Mass.)

SN - 1528-9117

IS - 2

ER -